BGPT: Author Review: Naisi Li

Explore by Goal

Low confidence. Please provide more context.

Quick Explanation Copied

Naisi Li (author) — scientific snapshot
Based on the provided OpenAlex record and listed works, Li’s publication themes concentrate on microbiome–immune and microbiome–metabolism interfaces (including gut motility/bile acids and host–microbe immune recognition) with examples such as gut MAIT-cell antigen recognition in colorectal cancer , microbiome-encoded bile-acid metabolism affecting colonic transit times , and microbiome-associated ACE2 expression variability .

Long Explanation

Author Review: Naisi Li

Evidence base used: provided OpenAlex snapshot + provided list of works (titles + DOIs/years when available). No full-text excerpts were supplied for these works, so mechanistic claims are limited to what’s explicitly indicated by the provided metadata.

1) What the publication record appears to emphasize (from titles/DOIs)

Microbiome ↔ host immunity (tumor microenvironment / antigen recognition). Example: MAIT cells showing hallmarks of bacterial antigen recognition in colorectal cancer .
Microbiome ↔ metabolic/physiology regulation (bile acids ↔ motility). Example: microbiome-encoded bile acid metabolism modulates colonic transit times .
Microbiome ↔ host gene expression (ACE2 variability). Example: variability in digestive and respiratory tract Ace2 expression is associated with the microbiome .
Microbiome ↔ disease association/biogeography. Examples: CRC-associated bacteria broadly distributed in global microbiomes and drivers of precancerous change , plus familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis .

Critical note (epistemic humility): without full text, I can’t verify study design details (e.g., causality vs association, confounding control, blinding, microbiome sampling depth, statistical calibration). So the “emphasis” above is based only on the provided metadata.

2) Visual: output/citation proxy over time (from provided OpenAlex snapshot)

Raw data used below is explicitly from your provided OpenAlex “counts_by_year” list (works_count + cited_by_count where present).

Skeptical read: “cited_by_count per year” here is a proxy from the snapshot, not an evaluation of experimental impact quality. Also, citation accrual varies strongly with time since publication.

3) Evidence-grade critique of the research themes (what’s plausible vs what’s unverified)

Theme A — immune recognition linked to bacterial antigens (MAIT cells)

Strength signals (from metadata only): direct focus on MAIT “hallmarks of bacterial antigen recognition” suggests mechanistic assays beyond simple taxonomy shifts .
Common blind spot to check in full text: MAIT phenotypes can be influenced by multiple stimuli (microbial metabolites, inflammatory cytokines, tumor context). Without full methods, I can’t confirm specificity controls.

Theme B — bile-acid metabolism affecting gut motility

Strength signals: the title and provided abstract language (metabolically phenotyped gnotobiotic colonization) strongly suggest causal probing with controlled communities .
Key skepticism to apply (in full text): motility phenotypes can be confounded by diet, stress, cage effects, circadian timing, and measurement method. The STAR Protocols-style work (below) suggests the group cares about transit assays, which is a positive sign for rigor .

Theme C — microbiome association with ACE2 expression variability

Strength signals: the paper frames host ACE2 variability in digestive and respiratory tracts in relation to microbiome state .
Most important alternative explanations to test: ACE2 expression depends on host genetics, inflammation state, and technical factors in sampling/quantification. Without full text, I can’t assess causal direction or confounder control.

Cross-paper “rigor proxy” observation: appearing both on a mechanistic biology paper (MAIT/bile acids/host gene expression) and a methods paper (STAR Protocols transit assays) can indicate attention to measurement/assay validity, which often correlates with better downstream interpretability .

4) Concrete work list (from provided metadata)

This table uses only the works you provided (titles + DOIs/years where present in your snapshot).

Year	Title (provided)	DOI / Link	Likely subdomain (title-derived)
2020	Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer	10.1016/j.xcrm.2020.100039	Immunology / tumor microenvironment / microbial antigens
2021	Microbiome-encoded bile acid metabolism modulates colonic transit times	10.1016/j.isci.2021.102508	Microbiome metabolism → host physiology
2021	Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome	10.1371/journal.pone.0248730	Host gene expression ↔ microbiome
2021	Marker-based assays for studying gut transit in gnotobiotic and conventional mouse models	10.1016/j.xpro.2021.100938	Methods / phenotyping
2023	Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity	10.1016/j.immuni.2023.06.024	Microbiome → immune disease (GvHD)
2024	Colorectal cancer-associated bacteria are broadly distributed in global microbiomes and drivers of precancerous change	10.1038/s41598-024-70702-1	Microbiome epidemiology / CRC association
2024	Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis	10.1038/s41598-024-60225-0	Microbiome signature in immune-mediated disease

5) Main scientific strengths & weaknesses (skeptical, evidence-limited)

Strengths (supported by metadata)

Mechanism-oriented microbiome work: topics include immune cell recognition of bacterial antigens and bile-acid metabolism impacting a physiological readout (motility) rather than only describing correlations .
Measurement rigor signals: co-authoring a STAR Protocols paper for gut transit assays suggests structured measurement development .

Weaknesses / uncertainties (what I would verify with full text)

Causality vs association: several themes (e.g., ACE2 expression variability; disease-associated microbiome signatures) can be correlational and sensitive to confounding. Full-text verification is essential .
Generalization across species/contexts: microbiome experiments in mice may not translate directly to human dynamics and exposure histories (species difference risk). This can be mitigated by parallel human sampling/validation, which must be checked in full text.
Measurement/analysis fragility: microbiome studies can be affected by batch effects, sequencing depth, compositionality, and bioinformatics pipeline choices. Without the analysis details, I can’t assess robustness.

6) What would disprove or change my current assessment?

If full texts show that mechanistic claims rely mostly on correlational patterns (e.g., no perturbation/causal tests) or lack appropriate controls, my confidence in “mechanism orientation” would drop.
If full texts reveal strong batch effects, inadequate normalization, or non-replicated key readouts, the rigor assessment would weaken.
If human relevance is asserted without independent validation cohorts or with limited effect sizes/low calibration, the translational strength would be reduced.

This will iteratively fetch/compute more from BGPT’s paper data (full text where available) to upgrade this review from metadata-limited to evidence-grounded.

Feedback:

Updated: April 21, 2026